These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6131656)

  • 1. alpha-Adrenergic receptor function in schizophrenia. Receptor number, cyclic adenosine monophosphate production, adenylate cyclase activity, and effect of drugs.
    Kafka MS; van Kammen DP
    Arch Gen Psychiatry; 1983 Mar; 40(3):264-70. PubMed ID: 6131656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced cyclic AMP production in the blood platelets from schizophrenic patients.
    Kafka MS; van Kammen DP; Bunney WE
    Am J Psychiatry; 1979 May; 136(5):685-7. PubMed ID: 219720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncoupling of alpha-adrenoceptor-mediated inhibition of human platelet adenylate cyclase by N-ethylmaleimide.
    Jakobs KH; Lasch P; Minuth M; Aktories K; Schultz G
    J Biol Chem; 1982 Mar; 257(6):2829-33. PubMed ID: 6277915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizophrenia and reduced cyclic AMP production: evidence for the role of receptor-linked events.
    Garver DL; Johnson C; Kanter DR
    Life Sci; 1982 Nov; 31(18):1987-92. PubMed ID: 6294425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acute methadone withdrawal on prostaglandin E-stimulated 3H-cyclic adenosine monophosphate accumulation in human platelets.
    Pandey GN; DeLeon-Jones FA; Inwang EE; Davis JM
    Clin Pharmacol Ther; 1980 May; 27(5):607-11. PubMed ID: 6245830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet prostaglandin E1 hyposensitivity in schizophrenia: reduction of prostaglandin E1- or forskolin-stimulated cyclic AMP response in platelets.
    Ofuji M; Kaiya H; Nozaki M; Tsurumi K
    Life Sci; 1989; 45(22):2135-40. PubMed ID: 2557518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormality of adenylate cyclase regulation in human platelet membranes in renal insufficiency.
    Jacobsson B; Ransnäs L; Nyberg G; Bergh CH; Magnusson Y; Hjalmarson A
    Eur J Clin Invest; 1985 Apr; 15(2):75-81. PubMed ID: 2986984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet prostaglandin E1 hyposensitivity in schizophrenia: decrease in cyclic AMP formation and in inhibitory effects on aggregation.
    Kaiya H; Ofuji M; Nozaki M; Tsurumi K
    Psychopharmacol Bull; 1990; 26(3):381-4. PubMed ID: 2177206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanisms of action of lithium. II. Effects on adenylate cyclase activity and beta-adrenergic receptor binding in normal subjects.
    Risby ED; Hsiao JK; Manji HK; Bitran J; Moses F; Zhou DF; Potter WZ
    Arch Gen Psychiatry; 1991 Jun; 48(6):513-24. PubMed ID: 1645514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-adrenergic receptors and cyclic AMP production in a group of schizophrenic patients.
    Kafka MS; Kleinman JE; Karson CN; Wyatt RJ
    Hillside J Clin Psychiatry; 1986; 8(1):15-24. PubMed ID: 3017834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets of pseudohypoparathyroid patients: evidence that distinct receptor-cyclase coupling proteins mediate stimulation and inhibition of adenylate cyclase.
    Motulsky HJ; Hughes RJ; Brickman AS; Farfel Z; Bourne HR; Insel PA
    Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4193-7. PubMed ID: 6287473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The local anaesthetic benzyl alcohol attenuates the alpha 2-adrenoceptor-mediated inhibition of human platelet adenylate cyclase activity when stimulated by prostaglandin E1, but not that stimulated by forskolin.
    Spence S; Houslay MD
    Biochem J; 1989 Dec; 264(2):483-8. PubMed ID: 2557841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone-sensitive adenylate cyclase. Delineation of a trypsin-sensitive site in the pathway of receptor-mediated inhibition.
    Stiles GL; Lefkowitz RJ
    J Biol Chem; 1982 Jun; 257(11):6287-91. PubMed ID: 6281265
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet alpha 2-adrenergic receptor function in psychiatric disorders.
    Kanof PD; Johns CA; Davidson M; Siever LJ; Coccaro EF; Davis KL
    Psychiatry Res; 1988 Jan; 23(1):11-22. PubMed ID: 2834762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficient guanine nucleotide regulatory unit activity in cultured fibroblast membranes from patients with pseudohypoparathyroidism type I. a cause of impaired synthesis of 3',5'-cyclic AMP by intact and broken cells.
    Levine MA; Eil C; Downs RW; Spiegel AM
    J Clin Invest; 1983 Jul; 72(1):316-24. PubMed ID: 6308048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
    Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
    Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of genes for metabolism of cyclic adenosine 3':5'-monophosphate in somatic cells. beta-Adrenergic and PGE1 receptors in parental and hybrid cells.
    Brunton LL; Maguire ME; Anderson HJ; Gilman AG
    J Biol Chem; 1977 Feb; 252(4):1293-302. PubMed ID: 190227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet alpha-adrenergic binding and biochemical responsiveness in depressed patients and controls.
    Siever LJ; Kafka MS; Targum S; Lake CR
    Psychiatry Res; 1984 Apr; 11(4):287-302. PubMed ID: 6330782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the human platelet alpha-adrenergic receptor. Correlation of [3H]dihydroergocryptine binding with aggregation and adenylate cyclase inhibition.
    Alexander RW; Cooper B; Handin RI
    J Clin Invest; 1978 May; 61(5):1136-44. PubMed ID: 207726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.